Abilita Therapeutics and Orion Announce Research Collaboration to Develop Next-Generation Antibody Therapeutics in the Areas of Oncology and Pain
Abilita Bio secures $7.5 million in equity financing from Two Bear Capital
Abilita Bio selected as one of San Diego’s ‘Cool Companies’ 2022
Abilita Bio will also participate as a ‘Cool Company’ to the first ‘San Diego Innovation Day’ event, organized by CONNECT on April 28 at Petko Park, San Diego. Link to the event Link to the ‘Cool Company’ site
Abilita Bio Announces Business Growth and Key Developments
